Brain Liquid Biopsy Assay
Creative Biolabs is at the forefront of scientific innovation, continuously striving to develop groundbreaking technologies that advance the field of neuroscience. Our latest cutting-edge service, the Brain Liquid Biopsy Assay, has revolutionized the field of neurological diagnostics. By harnessing the power of circulating tumor cells (CTCs) analysis, brain-derived exosomes analysis, and cfDNA analysis, our Brain Liquid Biopsy Assay service offers unparalleled insights into the complex workings of the brain and opens new avenues for diagnosis, monitoring, and treatment of neurological disorders.
Our Technology
At Creative Biolabs, we have developed a state-of-the-art platform that combines multiple cutting-edge technologies to enable comprehensive analysis of brain-derived biomarkers. By combining these approaches, our assay provides comprehensive insights into the neurological landscape of patients, leading to more accurate diagnoses and improved patient outcomes.
-
Circulating Tumor Cells (CTCs) Analysis
CTCs are rare cells shed by primary brain tumors into the bloodstream. The analysis of CTCs provides valuable information on tumor heterogeneity, enabling personalized treatment strategies and monitoring of treatment efficacy. Once captured and concentrated, these circulating tumor cells (CTCs) can be examined, offering insights into the current state of a disease. Importantly, our liquid biopsy technique is far less invasive for patients compared to the conventional surgical biopsy. -
cfDNA & cfRNA Analysis
Cell-free DNA (cfDNA) refers to the small fragments of DNA that circulate freely in the bloodstream. Our Brain Liquid Biopsy Assay includes the analysis of cfDNA derived from the brain, providing insights into various neurological conditions. By detecting specific genetic alterations, such as mutations or epigenetic modifications, cfDNA analysis can aid in the diagnosis and monitoring of brain tumors, neurodegenerative diseases, and psychiatric disorders. -
Brain-Derived Exosomes Analysis
Exosomes are small vesicles released by cells that contain a wealth of information about their molecular composition. In the context of the brain, brain-derived exosomes (neuronal, astrocyte, and oligodendrocyte origin) offer a unique window into the neurological landscape. Our Brain Liquid Biopsy Assay leverages advanced techniques to isolate and analyze these exosomes, enabling the identification of specific biomarkers associated with neurological disorders, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. This analysis can facilitate early detection, disease progression monitoring, and the development of targeted therapies.
Fig.1 CTCs capture, enrichment, and characterization.1
Fig.2 Liquid biopsy in brain tumor.2
Fig.3 Brain-originated exosomes (neuronal, astrocytic, and oligodendrocytic origin). 3
Highlight
Multi-platform Analysis
These platform technologies may include advanced molecular biology techniques, high-throughput sequencing, next-generation sequencing (NGS), single-cell analysis, and various other cutting-edge methodologies.
Customizability
We offer customized assay design services tailored to meet specific requirements. Our team of experienced scientists collaborates closely with clients to develop assays that target specific biomarkers, optimize sensitivity, and ensure reliable and reproducible results.
Precision
By maintaining strict protocols and standardized procedures, precision ensures that sample analysis data remains consistent and reliable, providing confidence in the results obtained from various locations worldwide.
Please contact us today to explore the potential for collaboration with our organization.
References
- Yang, Chaogang, et al. "Circulating tumor cells in gastrointestinal cancers: current status and future perspectives." Frontiers in oncology 9 (2019): 1427.
- Eibl, Robert H., and Markus Schneemann. "Liquid biopsy and primary brain tumors." Cancers 13.21 (2021): 5429.
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- NeuroMab™ Anti-SEZ6 Antibody(NRP-0422-P517) (Cat#: NRP-0422-P517)
- NeuroMab™ Anti-Integrin αvβ8 BBB Shuttle Antibody(NRZP-1222-ZP1218) (Cat#: NRZP-1222-ZP1218)
- NeuroMab™ Anti-pTau Antibody(NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- NeuroMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- NeuroMab™ Anti-ApoC3 BBB Shuttle Antibody(NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- NeuroMab™ Anti-TNFα BBB Shuttle Antibody(NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- Mouse Retinal Ganglion Cells (Cat#: NCL2110P145)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Mouse Microglia Cell Line BV-2, Immortalized (Cat#: NCL2110P153)
- iNeu™ Retinal Pigment Epithelial Cells (RPE) (Cat#: NRZP-0323-ZP92)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- pAAV-syn-FLEX-jGCaMP8m-WPRE (Cat#: NTA-2106-P065)
- AAV-EF1a-mCherry-flex-dtA (Cat#: NRZP-0622-ZP616)
- rAAV-CAG-DIO-G-Flamp1 (Cat#: NRZP-0722-ZP719)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- pAAV-syn-jGCaMP8f-WPRE (Cat#: NTA-2106-P061)
- AAV2/2Retro-CAG-DIO-EGFP-2A-TetTox-pA [Neural Tracing] (Cat#: NTA-2012-ZP303)
- AAV2/9-hEF1a-DIO-mCherry-P2A-TetTox-WPRE-pA (Cat#: NTA-2012-ZP268)
- pAAV-syn-FLEX-jGCaMP8s-WPRE (Cat#: NTA-2106-P066)
- pAAV-hSyn-DIO-XCaMP-R-WPRE (Cat#: NTA-2012AD-P508)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)